{"pmid":32407569,"title":"Supporting people with diabetes during a pandemic.","text":["Supporting people with diabetes during a pandemic.","In this issue, Joensen and colleagues present the first data we have seen on the impact and experience of diabetes through the lens of the COVID-19 pandemic. The research was completed in Denmark in March 2020, in the context of a marked shutdown of economic and social activities across the country, but without the devastating death tolls experienced by other Organisation for Economic Co-operation and Development (OECD) countries. There are several notable findings, which have global relevance, and we should take the time to reflect on these for our own localized contexts.","Diabet Med","Skinner, T","Speight, J","32407569"],"abstract":["In this issue, Joensen and colleagues present the first data we have seen on the impact and experience of diabetes through the lens of the COVID-19 pandemic. The research was completed in Denmark in March 2020, in the context of a marked shutdown of economic and social activities across the country, but without the devastating death tolls experienced by other Organisation for Economic Co-operation and Development (OECD) countries. There are several notable findings, which have global relevance, and we should take the time to reflect on these for our own localized contexts."],"journal":"Diabet Med","authors":["Skinner, T","Speight, J"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32407569","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1111/dme.14320","locations":["Denmark"],"countries":["Denmark"],"countries_codes":["DNK|Denmark"],"topics":["Prevention"],"weight":1,"_version_":1666802845549068288,"score":9.490897,"similar":[{"pmid":32392431,"title":"Role of Non-Profit Organization During COVID-19 for Diabetes Care: Healthcare Inequities and Role of Virtual Specialty Clinic.","text":["Role of Non-Profit Organization During COVID-19 for Diabetes Care: Healthcare Inequities and Role of Virtual Specialty Clinic.","Today, in the US, we have a health care system designed to treat symptoms, not people - and to do so as cheaply as possible with the dual goals of minimizing costs and preventing hospital visits. We are failing on all fronts. We spend more money on healthcare per capita than our Organization for Economic Co-operation and Development (OECD) peers, and our outcomes are mediocre at best. Medicine is not personal, health care professionals often have their hands tied by payers, and geography has too much influence on the quality of care available. This has to end, especially since we have the technology to create a truly patient-focused, whole-person approach - one that treats physical and mental health equally and meets people where they are in every sense. Telemedicine can level the playing field and enable higher-quality, decentralized care that - when needed - brings specialty care to the masses. Other technologies have an important role, too. For patients with insulin-dependent diabetes (type 1 diabetes), widespread uptake of continuous glucose monitors (CGM) the game-changer we need right now that can facilitate telemedicine to remote places and remove healthcare disparities. Health professionals and patients will both win - and ultimately payers will, too.","Diabetes Technol Ther","Panzirer, David","32392431"],"abstract":["Today, in the US, we have a health care system designed to treat symptoms, not people - and to do so as cheaply as possible with the dual goals of minimizing costs and preventing hospital visits. We are failing on all fronts. We spend more money on healthcare per capita than our Organization for Economic Co-operation and Development (OECD) peers, and our outcomes are mediocre at best. Medicine is not personal, health care professionals often have their hands tied by payers, and geography has too much influence on the quality of care available. This has to end, especially since we have the technology to create a truly patient-focused, whole-person approach - one that treats physical and mental health equally and meets people where they are in every sense. Telemedicine can level the playing field and enable higher-quality, decentralized care that - when needed - brings specialty care to the masses. Other technologies have an important role, too. For patients with insulin-dependent diabetes (type 1 diabetes), widespread uptake of continuous glucose monitors (CGM) the game-changer we need right now that can facilitate telemedicine to remote places and remove healthcare disparities. Health professionals and patients will both win - and ultimately payers will, too."],"journal":"Diabetes Technol Ther","authors":["Panzirer, David"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32392431","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1089/dia.2020.0219","locations":["US"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666528580256923648,"score":107.58552},{"pmid":32492613,"title":"COVID-19's impact on the atmospheric environment in the Southeast Asia region.","text":["COVID-19's impact on the atmospheric environment in the Southeast Asia region.","Since its first appearance in Wuhan, China at the end of 2019, the new coronavirus (COVID-19) has evolved a global pandemic within three months, with more than 4.3 million confirmed cases worldwide until mid-May 2020. As many countries around the world, Malaysia and other southeast Asian (SEA) countries have also enforced lockdown at different degrees to contain the spread of the disease, which has brought some positive effects on natural environment. Therefore, evaluating the reduction in anthropogenic emissions due to COVID-19 and the related governmental measures to restrict its expansion is crucial to assess its impacts on air pollution and economic growth. In this study, we used aerosol optical depth (AOD) observations from Himawari-8 satellite, along with tropospheric NO2 column density from Aura-OMI over SEA, and ground-based pollution measurements at several stations across Malaysia, in order to quantify the changes in aerosol and air pollutants associated with the general shutdown of anthropogenic and industrial activities due to COVID-19. The lockdown has led to a notable decrease in AOD over SEA and in the pollution outflow over the oceanic regions, while a significant decrease (27% - 30%) in tropospheric NO2 was observed over areas not affected by seasonal biomass burning. Especially in Malaysia, PM10, PM2.5, NO2, SO2, and CO concentrations have been decreased by 26-31%, 23-32%, 63-64%, 9-20%, and 25-31%, respectively, in the urban areas during the lockdown phase, compared to the same periods in 2018 and 2019. Notable reductions are also seen at industrial, suburban and rural sites across the country. Quantifying the reductions in major and health harmful air pollutants is crucial for health-related research and for air-quality and climate-change studies.","Sci Total Environ","Kanniah, Kasturi Devi","Kamarul Zaman, Nurul Amalin Fatihah","Kaskaoutis, Dimitris G","Latif, Mohd Talib","32492613"],"abstract":["Since its first appearance in Wuhan, China at the end of 2019, the new coronavirus (COVID-19) has evolved a global pandemic within three months, with more than 4.3 million confirmed cases worldwide until mid-May 2020. As many countries around the world, Malaysia and other southeast Asian (SEA) countries have also enforced lockdown at different degrees to contain the spread of the disease, which has brought some positive effects on natural environment. Therefore, evaluating the reduction in anthropogenic emissions due to COVID-19 and the related governmental measures to restrict its expansion is crucial to assess its impacts on air pollution and economic growth. In this study, we used aerosol optical depth (AOD) observations from Himawari-8 satellite, along with tropospheric NO2 column density from Aura-OMI over SEA, and ground-based pollution measurements at several stations across Malaysia, in order to quantify the changes in aerosol and air pollutants associated with the general shutdown of anthropogenic and industrial activities due to COVID-19. The lockdown has led to a notable decrease in AOD over SEA and in the pollution outflow over the oceanic regions, while a significant decrease (27% - 30%) in tropospheric NO2 was observed over areas not affected by seasonal biomass burning. Especially in Malaysia, PM10, PM2.5, NO2, SO2, and CO concentrations have been decreased by 26-31%, 23-32%, 63-64%, 9-20%, and 25-31%, respectively, in the urban areas during the lockdown phase, compared to the same periods in 2018 and 2019. Notable reductions are also seen at industrial, suburban and rural sites across the country. Quantifying the reductions in major and health harmful air pollutants is crucial for health-related research and for air-quality and climate-change studies."],"journal":"Sci Total Environ","authors":["Kanniah, Kasturi Devi","Kamarul Zaman, Nurul Amalin Fatihah","Kaskaoutis, Dimitris G","Latif, Mohd Talib"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492613","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.scitotenv.2020.139658","keywords":["aerosols","covid-19","himawari-8","no(2)","pollutants","southeast asia"],"locations":["Wuhan","China","Malaysia","Malaysia","Malaysia"],"countries":["Malaysia","China"],"countries_codes":["MYS|Malaysia","CHN|China"],"weight":0,"_version_":1668623433500459010,"score":106.28049},{"pmid":32502693,"title":"The Australian response to the COVID-19 pandemic and diabetes - lessons learned.","text":["The Australian response to the COVID-19 pandemic and diabetes - lessons learned.","The COVID-19 pandemic has had a significant impact on the economy and health system of most countries in the world and this is also true of Australia. Australia has not seen the huge surge of COVID-19 positive cases and subsequent hospitalisations and deaths experienced in other parts of the world. However there have been important social and health strategies to \"flatten\" the curve, to reduce infections and to manage those infected. These have included closure of international and interstate borders, local lockdown measures, physical distancing, shift to work from home, closure of non-essential businesses and full or partial closure of all schools and tertiary education facilities. From the diabetes care perspective, there was a significant and concerted diversion of hospital resources and staff to COVID-19 specific activities. Reduced access to primary care, diagnostic and hospital services for diabetes, combined with fear of exposure to the virus in these settings, led to a significant drop in access to usual diabetes care. Provision of outpatient and private sector diabetes services via telehealth was encouraged and supported by expanded and new government subsidies. Importantly, for the first time, there was government funded subsidy for care delivered via the telephone and inclusion of credentialled diabetes educators in funded telephone/telehealth support. The Australian health professional and consumer organisations worked cooperatively producing guidelines, position statements and other educational resources specific for the COVID-19 setting. Once the COVID-19 pandemic is over, review of all the changes will be important, determining which should be permanently implemented. The learnings from COVID-19 should help prepare Australia for future pandemics or other major health crises.","Diabetes Res Clin Pract","Andrikopoulos, Sof","Johnson, Greg","32502693"],"abstract":["The COVID-19 pandemic has had a significant impact on the economy and health system of most countries in the world and this is also true of Australia. Australia has not seen the huge surge of COVID-19 positive cases and subsequent hospitalisations and deaths experienced in other parts of the world. However there have been important social and health strategies to \"flatten\" the curve, to reduce infections and to manage those infected. These have included closure of international and interstate borders, local lockdown measures, physical distancing, shift to work from home, closure of non-essential businesses and full or partial closure of all schools and tertiary education facilities. From the diabetes care perspective, there was a significant and concerted diversion of hospital resources and staff to COVID-19 specific activities. Reduced access to primary care, diagnostic and hospital services for diabetes, combined with fear of exposure to the virus in these settings, led to a significant drop in access to usual diabetes care. Provision of outpatient and private sector diabetes services via telehealth was encouraged and supported by expanded and new government subsidies. Importantly, for the first time, there was government funded subsidy for care delivered via the telephone and inclusion of credentialled diabetes educators in funded telephone/telehealth support. The Australian health professional and consumer organisations worked cooperatively producing guidelines, position statements and other educational resources specific for the COVID-19 setting. Once the COVID-19 pandemic is over, review of all the changes will be important, determining which should be permanently implemented. The learnings from COVID-19 should help prepare Australia for future pandemics or other major health crises."],"journal":"Diabetes Res Clin Pract","authors":["Andrikopoulos, Sof","Johnson, Greg"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32502693","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.diabres.2020.108246","keywords":["australia","covid-19","diabetes care"],"locations":["Australia","Australia","Australian","Australia","Australian"],"countries":["Australia"],"countries_codes":["AUS|Australia"],"topics":["Prevention"],"weight":1,"_version_":1668804508688318464,"score":104.706635},{"pmid":32501754,"title":"Historical Insights on Coronavirus Disease 2019 (COVID-19), the 1918 Influenza Pandemic, and Racial Disparities: Illuminating a Path Forward.","text":["Historical Insights on Coronavirus Disease 2019 (COVID-19), the 1918 Influenza Pandemic, and Racial Disparities: Illuminating a Path Forward.","The coronavirus disease 2019 (COVID-19) pandemic is exacting a disproportionate toll on ethnic minority communities and magnifying existing disparities in health care access and treatment. To understand this crisis, physicians and public health researchers have searched history for insights, especially from a great outbreak approximately a century ago: the 1918 influenza pandemic. However, of the accounts examining the 1918 influenza pandemic and COVID-19, only a notable few discuss race. Yet, a rich, broader scholarship on race and epidemic disease as a \"sampling device for social analysis\" exists. This commentary examines the historical arc of the 1918 influenza pandemic, focusing on black Americans and showing the complex and sometimes surprising ways it operated, triggering particular responses both within a minority community and in wider racial, sociopolitical, and public health structures. This analysis reveals that critical structural inequities and health care gaps have historically contributed to and continue to compound disparate health outcomes among communities of color. Shifting from this context to the present, this article frames a discussion of racial health disparities through a resilience approach rather than a deficit approach and offers a blueprint for approaching the COVID-19 crisis and its afterlives through the lens of health equity.","Ann Intern Med","Krishnan, Lakshmi","Ogunwole, S Michelle","Cooper, Lisa A","32501754"],"abstract":["The coronavirus disease 2019 (COVID-19) pandemic is exacting a disproportionate toll on ethnic minority communities and magnifying existing disparities in health care access and treatment. To understand this crisis, physicians and public health researchers have searched history for insights, especially from a great outbreak approximately a century ago: the 1918 influenza pandemic. However, of the accounts examining the 1918 influenza pandemic and COVID-19, only a notable few discuss race. Yet, a rich, broader scholarship on race and epidemic disease as a \"sampling device for social analysis\" exists. This commentary examines the historical arc of the 1918 influenza pandemic, focusing on black Americans and showing the complex and sometimes surprising ways it operated, triggering particular responses both within a minority community and in wider racial, sociopolitical, and public health structures. This analysis reveals that critical structural inequities and health care gaps have historically contributed to and continue to compound disparate health outcomes among communities of color. Shifting from this context to the present, this article frames a discussion of racial health disparities through a resilience approach rather than a deficit approach and offers a blueprint for approaching the COVID-19 crisis and its afterlives through the lens of health equity."],"journal":"Ann Intern Med","authors":["Krishnan, Lakshmi","Ogunwole, S Michelle","Cooper, Lisa A"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32501754","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.7326/M20-2223","locations":["Americans"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1668804508671541248,"score":95.08701},{"pmid":32392380,"title":"Diabetes and COVID-19: psychosocial consequences of the COVID-19 pandemic in people with diabetes in Denmark-what characterizes people with high levels of COVID-19-related worries?","text":["Diabetes and COVID-19: psychosocial consequences of the COVID-19 pandemic in people with diabetes in Denmark-what characterizes people with high levels of COVID-19-related worries?","AIM: To map COVID-19-specific worries and overall psychosocial health among people with diabetes in the initial phase of the COVID-19 pandemic in Denmark, and to explore characteristics of people with diabetes and high levels of worries related to the COVID-19 pandemic. METHODS: A cross-sectional survey was conducted by distributing online questionnaires to 2430 adult members (> 18 years) of two user panels consisting of people with diabetes who have volunteered to share information about their life with diabetes. The questionnaire included items on COVID-19-specific worries as well as such worries related to diabetes, sociodemographic and health status, social relations, diabetes-specific social support, diabetes distress and changes in diabetes-specific behaviours. Responses were analysed with descriptive statistics and logistic regressions. RESULTS: People with diabetes have COVID-19-specific worries related to their diabetes. More than half were worried about being overly affected due to diabetes if infected with COVID-19, about one-third about being characterized as a risk group due to diabetes and not being able to manage diabetes if infected. Logistic regressions showed that being female, having type 1 diabetes, diabetes complications and diabetes distress, feeling isolated and lonely, and having changed diabetes behaviours were associated with being more worried about COVID-19 and diabetes. CONCLUSION: People with diabetes have COVID-19-specific worries related to their diabetes which is associated with poorer psychosocial health. These worries should be addressed through support targeting specific questions and needs of individuals with diabetes as well as frequent updates on new knowledge regarding COVID-19 and diabetes.","Diabet Med","Joensen, L E","Madsen, K P","Holm, L","Nielsen, K A","Rod, M H","Petersen, A A","Rod, N H","Willaing, I","32392380"],"abstract":["AIM: To map COVID-19-specific worries and overall psychosocial health among people with diabetes in the initial phase of the COVID-19 pandemic in Denmark, and to explore characteristics of people with diabetes and high levels of worries related to the COVID-19 pandemic. METHODS: A cross-sectional survey was conducted by distributing online questionnaires to 2430 adult members (> 18 years) of two user panels consisting of people with diabetes who have volunteered to share information about their life with diabetes. The questionnaire included items on COVID-19-specific worries as well as such worries related to diabetes, sociodemographic and health status, social relations, diabetes-specific social support, diabetes distress and changes in diabetes-specific behaviours. Responses were analysed with descriptive statistics and logistic regressions. RESULTS: People with diabetes have COVID-19-specific worries related to their diabetes. More than half were worried about being overly affected due to diabetes if infected with COVID-19, about one-third about being characterized as a risk group due to diabetes and not being able to manage diabetes if infected. Logistic regressions showed that being female, having type 1 diabetes, diabetes complications and diabetes distress, feeling isolated and lonely, and having changed diabetes behaviours were associated with being more worried about COVID-19 and diabetes. CONCLUSION: People with diabetes have COVID-19-specific worries related to their diabetes which is associated with poorer psychosocial health. These worries should be addressed through support targeting specific questions and needs of individuals with diabetes as well as frequent updates on new knowledge regarding COVID-19 and diabetes."],"journal":"Diabet Med","authors":["Joensen, L E","Madsen, K P","Holm, L","Nielsen, K A","Rod, M H","Petersen, A A","Rod, N H","Willaing, I"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32392380","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1111/dme.14319","locations":["Denmark","Denmark"],"countries":["Denmark"],"countries_codes":["DNK|Denmark"],"weight":0,"_version_":1666528580162551808,"score":90.52499}]}